Cohance Lifesciences Limited (BOM:543064)

India · Delayed Price · Currency is INR

451.55

+10.95 (2.49%)

At close: Jul 10, 2026

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
Contract Development and Manufacturing Operations (CDMO)	22.69B	26.09B	10.51B	13.40B		10.10B
Contract Development and Manufacturing Operations (CDMO) Growth	-13.03%	148.11%	-21.56%	-		21.10%
Total	22.69B	26.09B	10.51B	13.40B		10.10B
Total Growth	-13.03%	148.11%	-21.56%	-		21.10%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	Mar '20 Mar 31, 2020	Mar '19 Mar 31, 2019
USA	1.48B	833.90M		717.54M
USA Growth	77.17%	-		42.92%
Europe	7.36B	11.62B		8.27B
Europe Growth	-36.63%	-		26.12%
India	964.40M	259.34M		430.78M
India Growth	271.87%	-		8.99%
Rest of The World	536.50M	600.13M		678.65M
Rest of The World Growth	-10.60%	-		-23.15%
Total	10.34B	13.31B		10.10B
Total Growth	-22.32%	-		21.10%